Participation of leukaemia inhibitory factor in follicular development and steroidogenesis in rat ovaries. 2023

S Peña, and M Rubio, and C Vargas, and C Alanis, and A H Paredes
Center for Neurobiochemical studies in Endocrine Diseases, Laboratory of Neurobiochemistry, Department of Biochemistry and Molecular Biology, Faculty of Chemistry and Pharmaceutical Sciences, Universidad de Chile, Santiago, Chile.

Leukaemia inhibitory factor (LIF) is a cytokine belonging to the interleukin-6 family that is important at the reproductive level in the uterine implantation process. However, there is very little evidence regarding its effect at the ovarian level. The aim of this work was to study the local involvement of the LIF/LIFRβ system in follicular development and steroidogenesis in rat ovaries. To carry out this research, LIF/LIFR/GP130 transcript and protein levels were measured in fertile and sub-fertile rat ovaries, and in vitro experiments were performed to assess STAT3 activation. Then, in in vivo experiments, LIF was administered chronically and locally for 28 days to the ovaries of rats by means of an osmotic minipump to enable us to evaluate the effect on folliculogenesis and steroidogenesis. It was determined by quantitative polymerase chain reaction and western blot that LIF and its receptors are present in fertile and sub-fertile ovaries and that LIF varies during the oestrous cycle, being higher during the oestrus and meta/dioestrus stages. In addition to this, it was found that LIF can activate STAT3 pathways and cause pSTAT3 formation. It was also observed that LIF decreases the number and size of preantral and antral follicles without altering the number of atretic antral follicles and can increase the number of corpora lutea, with a notable increase in the levels of progesterone (P4). It is therefore possible to infer that LIF exerts an important effect in vivo on folliculogenesis, ovulation and steroidogenesis, specifically the synthesis of P4.

UI MeSH Term Description Entries
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D010060 Ovulation The discharge of an OVUM from a rupturing follicle in the OVARY. Ovulations
D003338 Corpus Luteum The yellow body derived from the ruptured OVARIAN FOLLICLE after OVULATION. The process of corpus luteum formation, LUTEINIZATION, is regulated by LUTEINIZING HORMONE. Corpora Lutea,Lutea, Corpora
D005260 Female Females
D006080 Ovarian Follicle An OOCYTE-containing structure in the cortex of the OVARY. The oocyte is enclosed by a layer of GRANULOSA CELLS providing a nourishing microenvironment (FOLLICULAR FLUID). The number and size of follicles vary depending on the age and reproductive state of the female. The growing follicles are divided into five stages: primary, secondary, tertiary, Graafian, and atretic. Follicular growth and steroidogenesis depend on the presence of GONADOTROPINS. Graafian Follicle,Atretic Follicle,Ovarian Follicles,Atretic Follicles,Follicle, Atretic,Follicle, Graafian,Follicle, Ovarian,Follicles, Atretic,Follicles, Graafian,Follicles, Ovarian,Graafian Follicles
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D053605 Leukemia Inhibitory Factor An INTERLEUKIN-6 related cytokine that exhibits pleiotrophic effects on many physiological systems that involve cell proliferation, differentiation, and survival. Leukemia inhibitory factor binds to and acts through the lif receptor. AM424,Cholinergic Differentiation Factor,D Factor (Leukemia Inhibitory Factor),Differentiation-Stimulating Factor,Emfilermin,Myeloid Differentiation-Stimulating Factor,Differentiation Factor, Cholinergic,Differentiation Stimulating Factor,Differentiation-Stimulating Factor, Myeloid,Inhibitory Factor, Leukemia,Myeloid Differentiation Stimulating Factor

Related Publications

S Peña, and M Rubio, and C Vargas, and C Alanis, and A H Paredes
February 1999, Human reproduction (Oxford, England),
S Peña, and M Rubio, and C Vargas, and C Alanis, and A H Paredes
June 1997, Human reproduction (Oxford, England),
S Peña, and M Rubio, and C Vargas, and C Alanis, and A H Paredes
December 1983, Biology of reproduction,
S Peña, and M Rubio, and C Vargas, and C Alanis, and A H Paredes
January 1967, Acta morphologica Academiae Scientiarum Hungaricae,
S Peña, and M Rubio, and C Vargas, and C Alanis, and A H Paredes
May 2002, Molecular and cellular endocrinology,
S Peña, and M Rubio, and C Vargas, and C Alanis, and A H Paredes
January 1984, The International journal of biochemistry,
S Peña, and M Rubio, and C Vargas, and C Alanis, and A H Paredes
December 1977, Endocrinology,
S Peña, and M Rubio, and C Vargas, and C Alanis, and A H Paredes
March 2024, Scientific reports,
S Peña, and M Rubio, and C Vargas, and C Alanis, and A H Paredes
October 2007, Acta medica Okayama,
S Peña, and M Rubio, and C Vargas, and C Alanis, and A H Paredes
November 1966, Nature,
Copied contents to your clipboard!